Khosla Ventures — 2016 Investments
16 investments dated 2016 · listed companies and verified rows first · show all
Securing the world's data
Palo Alto, US
Bipul Sinha(Founder)inArvind Nithrakashyap(Founder)inArvind Jain(Founder)inSoham Mazumdar(Founder)inKiran Choudary(Chief Financial Officer)inJesse Green(Chief Revenue Officer)in
Co-investors3Spoke CapitalAccess Ventures (New York)Adit Ventures Management, LlcAnicut CapitalBain Capital VenturesChamaeleon+24 more
Medisas develops software to modernize hospital information systems and clinical workflows, enabling safer and more effective patient care by replacing outdated communication infrastructure with intuitive digital tools.
AI & Machine LearningCloud ComputingDigital HealthEnterprise SoftwareHealthtechSan Francisco, US
Gautam Sivakumar(CEO)inDustin Chang(CTO)Lynne Tye(Frontend Developer Consultant)in
Board seatKeith Rabois· per SEC Form D
Co-investorsCota CapitalFundersClubY CombinatorACE & CompanyAndreessen HorowitzFCVC+2 more
San Francisco, US
Adrian Aoun(Founder)Daniel Yoon(Founder)inDarryl Luo(Founder)inErik Frey(Founder)Ilya Abyzov(Founder)Riley Janjis(Founder)in
Board seatKeith Rabois· per SEC Form D · $30M raise · filed Jul 2016
Co-investorsBling CapitalBY Venture PartnersExpaJazzya InvestmentsTuesday CapitalWestern Technology Investment+1 more
AirHelp provides technology to help air passengers claim compensation for delayed and cancelled flights.
ConsumerLegalTechSaaSTravel & HospitalityLisbon, PT
Henrik Zillmer(Founder)inNicolas Michaelsen(Founder)inGreg Roodt(Technical Advisor)inTomasz Pawliszyn(CEO)inAlex Chang(Investor)in
Co-investorsABRY PartnersAngel Capital ManagementAnya CapitalTempoCapUpslope VenturesXG Ventures+17 more
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
Ming Wu(Director)inIgor Khandros(Executive Officer, Director)
BoardMichael Marks(Director)inLip-Bu Tan Tan(Director)Michael Moritz(Director)inWilliam Davidow(Director)
Co-investorsCelesta CapitalCota CapitalLucas Venture GroupOpen Field CapitalShangBay Capital LLCWalden Catalyst+5 more
Cape Analytics provides CAPE Property Intelligence, using geospatial imagery analytics and computer vision to generate predictive property risk insights.
AI & Machine LearningInsurTechPropTech
Ryan Kottenstette(Founder)Suat Gedikli(Founder)
Co-investorsAquiline Technology GrowthBrewer Lane VenturesDCVC (Data Collective)Gen CapitalIn-Q-TelLux Capital+6 more
Color operates a nationwide, oncologist-led Virtual Cancer Clinic that delivers cancer screening, early detection, diagnosis, treatment management, and survivorship care at population scale.
AI & Machine LearningBiotechDigital HealthHealthtechBurlingame, US
Othman Laraki(CEO)inElad Gil(Executive Officer, Director)in
BoardTaneja Hemant(Director)
Co-investorsNat TurnerVenture Capital Investment Management8VCGeneral Catalyst
CRISPR Therapeutics is a biotechnology company developing gene-based medicines using CRISPR/Cas9 gene-editing technology.
BiotechDeep TechHealthtechZug, CH
Emmanuelle Charpentier(Founder)Samarth Kulkarni(Chief Executive Officer and Chairman of the Board)inJames R. Kasinger(General Counsel and Secretary)inStephen Kennedy(Head of Technical Operations)inMegan Wherry Menner(Head of Human Resources)inNaimish Patel(Chief Medical Officer)in
Co-investorsAvoro Capital AdvisorsCLI VenturesNew Enterprise Associates (NEA)SR One Capital ManagementVersant VenturesWellington Management+2 more
Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records.
Digital HealthHardwareHealthtechMedical DevicesSan Diego, US
Cary Gunn(Founder)in
Co-investorsBioBritBoutique Venture PartnersClaremont Creek VenturesCLI VenturesFusionX VenturesHBM Healthcare Investments+7 more
D2iQ (formerly Mesosphere) provided Kubernetes automation and management technology for enterprise cloud-native and hybrid multicloud environments; it is now part of Nutanix, with its DKP product evolved into the Nutanix Kubernetes Platform (NKP).
Cloud ComputingDeveloper ToolsEnterprise SoftwareSan Francisco, US
Tobias Knaup(Executive Officer, Director)Florian Leibert(Executive Officer, Director)Tobi Knaup(Founder)inWilliam Freiberg(Executive Officer)
BoardPeter Levine(Director)inBruce Armstrong(Director)in
Co-investors3Spoke CapitalAndreessen HorowitzFuel CapitalKoch Disruptive TechnologiesM12 (Microsoft's Venture Fund)SV Angel+2 more
Moderna develops mRNA-based medicines for infectious and serious diseases using its proprietary mRNA platform and design technology.
BiotechDeep TechMedical DevicesCambridge, US
Robert Langer(Founder)Noubar Afeyan, Ph.D.(Co-founder and Chairman, Moderna; CEO, Flagship Pioneering)Lorence Kim(Executive Officer)inJames R. Kasinger(Executive Officer)inStephen Hoge(Executive Officer)inDerrick Rossi(Founder)
Co-investorsAglae VenturesBlackstone Life SciencesFlagship PioneeringFPVLingottoPremji Invest+5 more
Hybrid-cloud data management software and services for the enterprise market.
Campbell, US
John Taylor(Executive Officer, Director)inPatrick Harr(Executive Officer, Director)
BoardAndrew Verhalen(Director)inPaul Madera(Director)inGill Cogan(Director)Mark Santora(Director)
Co-investorsAquiline Technology GrowthChevron Technology VenturesMatrixMeritech Capital PartnersOpus Capital
PatientBank provides a platform for patients to collect and distribute their medical records from multiple healthcare providers in one place.
HealthtechNew York City, US
Feridun Mert Celebi(CTO)inPaul Fletcher-Hill(CEO)Graham Kaemmer(Engineer)Kevin Grassi(Chief Medical Officer)Eric Yu(Software Engineer)in
Co-investorsY CombinatorDCVC (Data Collective)Four CitiesGeneral CatalystS28 CapitalSV Angel
Herndon, US
Gregory Gutt(Executive Officer, Director)inMichael O'Connor(Executive Officer, Director)
BoardRohit Braggs(Director)Rich Perry(Director)Walter C. Melton(Director)Arunas A. Chesonis(Director)in
Co-investorsSafar Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








































.png)



































